BELDEN INC

There have been no material changes with respect to risk factors as previously disclosed in our Form 10-K filed on February 13, 2024. There may be additional risks that impact our business that we currently do not recognize as, or that are not currently, material to our business.

Set forth below is information regarding our stock repurchases for the three months ended September 29, 2024 (in thousands, except per share amounts).

(1)We have a share repurchase program which allows us to purchase our common stock through open market repurchases, negotiated transactions, or other means, in accordance with applicable securities laws and other restrictions. This program is funded with cash on hand and cash flows from operating activities. The program does not have an expiration date and may be suspended at any time at the discretion of the Company. During September 2024, our Board of Directors increased the authorizations under this program by $300.0 million. During the three months ended September 29, 2024, we repurchased 0.2 million shares of our common stock for an aggregate cost of $20.1 million at an average price per share of $110.84. Subsequent to September 29, 2024, we repurchased 0.3 million shares of our common stock for an aggregate cost of $37.6 million at an average price per share of $116.90. As of the date of this filing, we had $357.3 million of authorizations remaining under the program. See Note 15.